Moreover, GC patient serum-derived IL-6 and IL-8 activate and induce MDSCs to express arginase I via the PI3K-AKT signaling pathway, which in turn inhibits the activity of CD8 + T cells(Fig. 8) [105]. The gene discussed is CXCL8; the disease is gastric cancer.